NCB Busts Another Illegal Drug Factory In Vapi

Ahmedabad : The Ahmedabad Zonal Unit of the Narcotics Control Bureau on Saturday busted an illegal drug manufacturing facility in Vapi city of Valsad district in Gujarat.

The agency seized 68 kg of raw ingredients used to manufacture Alprazolam and Nordiazepam tablets, which can be processed and sold only on receipt of government license and only in restricted quantities.

The Active Pharmaceutical Ingredients (API) used in the manufacture of the prescription drugs were found in powder form, and sources in the NCB said four persons apprehended in the case were allegedly about to make tablets from the drug and illegally sell it in other states.

While Alprazolam is popularly marketed as Xanax and is used to treat anxiety and panic attacks, Nordazepam is an anticonvulsant, muscle relaxant and has sedative properties. Their misuse as substance abuse is well documented in India and other countries.

Of the four persons apprehended, two are residents of Maharashtra while the other two are from Telangana.
Sources told Mirror that the accused were under surveillance and NCB raided the premises on June 4 where they found incriminating evidence of illegal manufacture of the drugs along with equipment required to do so successfully.

This is the second backyard drug manufacturing unit busted in Gujarat by the NCB. In August 2021, it raided an inter-state drug cartel that was manufacturing Mephedrone, also in Vapi city.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 15 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 46 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt